Fentanyl Safe Testing and Overdose Prevention Act
This bill clarifies that equipment used to test for fentanyl or xylazine in substances is not subject to restrictions under the Controlled Substances Act. It directly affects people who use drugs and harm reduction organizations providing testing supplies. The key provision amends Section 422 of the Act to explicitly state that testing equipment for these substances is exempt from legal restrictions on possession, sale, or transportation. This allows safer access to testing tools without legal penalties. The bill does not create new programs or funding, only adjusting existing legal language.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
President
Introduced Jul 27, 2023
Last action Jul 27, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jul 27, 2023
Committee
Read twice and referred to the Committee on the Judiciary.
upper
Jul 27, 2023
Introduced
Introduced in Senate
upper
1 primary · 11 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
John Cornyn
RRepublican
Co
Amy Klobuchar
DDemocratic
Co
Bill Cassidy
RRepublican
Co
Chris Van Hollen
DDemocratic
Co
Christopher A. Coons
DDemocratic
Co
Gary C. Peters
DDemocratic
Co
Jacky Rosen
DDemocratic
Co
Kyrsten Sinema
IIndependent
Co
Raphael G. Warnock
DDemocratic
Co
Robert P. Casey, Jr.
DDemocratic
Co
Tammy Baldwin
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2569
Scope: US
Hi! I can help you understand S 2569. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline